CS216348B1 - Derivatives of the 4-/3-iodpropargyloxy/pyrimidine - Google Patents

Derivatives of the 4-/3-iodpropargyloxy/pyrimidine Download PDF

Info

Publication number
CS216348B1
CS216348B1 CS804192A CS419280A CS216348B1 CS 216348 B1 CS216348 B1 CS 216348B1 CS 804192 A CS804192 A CS 804192A CS 419280 A CS419280 A CS 419280A CS 216348 B1 CS216348 B1 CS 216348B1
Authority
CS
Czechoslovakia
Prior art keywords
formula
halogen atom
pyrimidine
alkali metal
alkyl
Prior art date
Application number
CS804192A
Other languages
Czech (cs)
English (en)
Inventor
Dusan Hesoun
Bohumir Vondracek
Jana Turinova
Original Assignee
Dusan Hesoun
Bohumir Vondracek
Jana Turinova
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dusan Hesoun, Bohumir Vondracek, Jana Turinova filed Critical Dusan Hesoun
Priority to CS804192A priority Critical patent/CS216348B1/cs
Priority to FR8110298A priority patent/FR2484416A1/fr
Priority to FI811610A priority patent/FI811610L/fi
Priority to NL8102670A priority patent/NL8102670A/nl
Priority to JP8451381A priority patent/JPS5716871A/ja
Priority to DE19813122836 priority patent/DE3122836A1/de
Priority to GB8117879A priority patent/GB2078222B/en
Priority to BE0/205081A priority patent/BE889204A/fr
Priority to SE8103702A priority patent/SE8103702L/xx
Priority to CA000379699A priority patent/CA1138455A/fr
Priority to DK258281A priority patent/DK258281A/da
Priority to US06/273,444 priority patent/US4384118A/en
Publication of CS216348B1 publication Critical patent/CS216348B1/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56—One oxygen atom and one sulfur atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
CS804192A 1980-06-13 1980-06-13 Derivatives of the 4-/3-iodpropargyloxy/pyrimidine CS216348B1 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
CS804192A CS216348B1 (en) 1980-06-13 1980-06-13 Derivatives of the 4-/3-iodpropargyloxy/pyrimidine
FR8110298A FR2484416A1 (fr) 1980-06-13 1981-05-22 Derives 4-(3-iodopropargyloxy) pyrimidine et procede pour la production de ces derives
FI811610A FI811610L (fi) 1980-06-13 1981-05-26 Foerfarande foer framstaellning av 4-(3-jodpropargyloxi)pyrimidinderivat
NL8102670A NL8102670A (nl) 1980-06-13 1981-06-02 4-(3-joodpropargyloxy)-pyrimidinederivaten en werkwijze ter bereiding daarvan.
JP8451381A JPS5716871A (en) 1980-06-13 1981-06-03 Pyrimidine derivative and manufacture
DE19813122836 DE3122836A1 (de) 1980-06-13 1981-06-09 4-(3-jodpropargyloxy)-pyrimidinderivate, ihre herstellung und pharmazeutische mittel
GB8117879A GB2078222B (en) 1980-06-13 1981-06-11 4-(3-iodopropargyloxy)pyrimidines
BE0/205081A BE889204A (fr) 1980-06-13 1981-06-12 Derives de 4-(3-iodopropargyloxy)-pyrimidine et leur procede de preparation
SE8103702A SE8103702L (sv) 1980-06-13 1981-06-12 4-(3-jodopropargyloxi)pyrimidinderivat och forfarande for framstellning derav
CA000379699A CA1138455A (fr) 1980-06-13 1981-06-12 Derives de la 4-(3-iodopropargyloxy) pyrimidine et methode pour les fabriquer
DK258281A DK258281A (da) 1980-06-13 1981-06-12 4-(3-jodpropargyloxy) pyrimidinderivater og fremgangsmaade til deres fremstilling
US06/273,444 US4384118A (en) 1980-06-13 1981-06-15 4-(3-Iodopropargyloxy) pyrimidine derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS804192A CS216348B1 (en) 1980-06-13 1980-06-13 Derivatives of the 4-/3-iodpropargyloxy/pyrimidine

Publications (1)

Publication Number Publication Date
CS216348B1 true CS216348B1 (en) 1982-10-29

Family

ID=5384104

Family Applications (1)

Application Number Title Priority Date Filing Date
CS804192A CS216348B1 (en) 1980-06-13 1980-06-13 Derivatives of the 4-/3-iodpropargyloxy/pyrimidine

Country Status (12)

Country Link
US (1) US4384118A (fr)
JP (1) JPS5716871A (fr)
BE (1) BE889204A (fr)
CA (1) CA1138455A (fr)
CS (1) CS216348B1 (fr)
DE (1) DE3122836A1 (fr)
DK (1) DK258281A (fr)
FI (1) FI811610L (fr)
FR (1) FR2484416A1 (fr)
GB (1) GB2078222B (fr)
NL (1) NL8102670A (fr)
SE (1) SE8103702L (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4933190A (en) * 1986-12-23 1990-06-12 Warner-Lambert Co. Multiple encapsulated sweetener delivery system
JP3244051B2 (ja) 1998-05-28 2002-01-07 日本電気株式会社 リレー通信システムとそのデータ転送保証監視方法及びそれに用いる通信機
AUPQ765300A0 (en) * 2000-05-22 2000-06-15 Commonwealth Scientific And Industrial Research Organisation Novel antibiotic compounds
WO2002024663A2 (fr) 2000-09-19 2002-03-28 Sumitomo Chemical Company, Limited Composes pyrimidiques et leur utilisation
WO2004085407A1 (fr) * 2003-03-27 2004-10-07 Sumitomo Chemical Company, Limited Compose de pyrimidine et agent de lutte contre les arthropodes contenant celui-ci

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3980781A (en) * 1966-03-31 1976-09-14 Imperial Chemical Industries Limited Fungicidal composition and method containing 2-amino-pyrimidines
BE792632A (fr) * 1971-12-15 1973-03-30 Spofa Usines Pharma Reunies Procede de preparation de nouvelles 5-/3-iodopropargyloxy/pyrimidines ainsi que les produits obtenus

Also Published As

Publication number Publication date
GB2078222A (en) 1982-01-06
BE889204A (fr) 1981-10-01
DK258281A (da) 1981-12-14
FR2484416A1 (fr) 1981-12-18
CA1138455A (fr) 1982-12-28
JPS5716871A (en) 1982-01-28
SE8103702L (sv) 1981-12-14
GB2078222B (en) 1983-09-28
FI811610L (fi) 1981-12-14
US4384118A (en) 1983-05-17
DE3122836A1 (de) 1982-04-01
NL8102670A (nl) 1982-01-04

Similar Documents

Publication Publication Date Title
US4110338A (en) Product and preparation of 1H-tetrazole-5-thiol derivatives
JPH05140080A (ja) フエニルスルホンアミド誘導体
DK144525B (da) Analogifremgangsmaade til fremstilling af 5-halogenpyrimid-2-oner eller salte deraf
PL90713B1 (fr)
US3794641A (en) Substituted phthalimido-1,3,5-triazines
EP3541799A1 (fr) Procédés de préparation de 4-((6-(2-(2,4-difluorophényl)-1,1-difluoro-2-hydroxy-3-(5-mercapto-1h-1,2,4-triazol-1-yl)propyl)pyridin-3-yl)oxy)benzonitrile
CS216348B1 (en) Derivatives of the 4-/3-iodpropargyloxy/pyrimidine
HU181841B (en) Herbicide composition further process for preparing imidazoline derivatives as active substances
SE443977B (sv) Forfarande for framstellning av 5(6)-tio-bensimidazolderivat
JP2014505043A (ja) Ｎ−スルホニル−置換オキシインドール類を製造する方法
HU193501B (en) Process for preparing substututed 2-amino-benzimidazoles
US3437665A (en) Process for preparing 1-aryl-5-chloro-1h-tetrazole
JPH07110829B2 (ja) ５，８−ジクロロ−１，４，９，１０−アントラセンテトロン
EP3004065B1 (fr) Procede de preparation d'un compose pyridazine
JPH07267931A (ja) スルホンアミド誘導体の製造方法
PL119712B1 (en) Process for preparing 6-piperidin-2,4-diaminopyrimidine 3-oxideina
US4338452A (en) 1-and 2-(1-Alkyl-1H-tetrazol-5-yl-methyl)-1H-tetrazol-5-thiols and 1-cyanomethyl tetrazole-5-thiol
US5936093A (en) Process for preparing pyridylmethyl isothiocyanates
DK166321B (da) Fremgangsmaade til fremstilling af 2-hydrazino-1,3-diazacycloalk-2-en-hydrohalogenider
EP0081859A2 (fr) Procédé pour la préparation de la cimétidine
JP3602796B2 (ja) チオバルビツール酸誘導体の製法
Loksha et al. Studying the synthesis of 4‐tert‐butyl‐1, 3‐dihydroimidazol‐2‐ones and their corresponding thiones
USRE28865E (en) Selective dehalogenation
JPH05222034A (ja) ５−置換シトシンおよび他の４，５−ジ置換ピリミジン−２（１ｈ）−オンの製法およびこの方法の過程で形成される中間体
EP0515464B1 (fr) Procede de preparation de derives d'uracile